Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERENUMAB-AOOE for Off label use: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 116 adverse event reports in the FDA FAERS database where ERENUMAB-AOOE was used for Off label use.

Most Reported Side Effects for ERENUMAB-AOOE

Side Effect Reports % Deaths Hosp.
Accidental exposure to product 9,923 19.8% 1 40
Device difficult to use 9,530 19.0% 3 109
Wrong technique in product usage process 9,359 18.7% 1 80
Drug dose omission by device 6,340 12.7% 1 74
Migraine 4,290 8.6% 468 736
Drug ineffective 3,813 7.6% 577 648
Constipation 3,104 6.2% 2 174
Product storage error 2,958 5.9% 0 23
Headache 2,787 5.6% 517 681
Injection site pain 2,715 5.4% 2 50
Off label use 2,227 4.4% 983 962
Nausea 1,929 3.9% 512 612
Alopecia 1,924 3.8% 621 589
Fatigue 1,829 3.7% 530 590
Therapeutic product effect incomplete 1,761 3.5% 265 264

Other Indications for ERENUMAB-AOOE

Product used for unknown indication (19,343) Migraine (19,137) Migraine prophylaxis (9,326) Headache (902) Migraine without aura (858) Migraine with aura (198) Rheumatoid arthritis (153) Cluster headache (71) Foetal exposure during pregnancy (71) Hemiplegic migraine (45)

Other Drugs Used for Off label use

LENALIDOMIDE (5,767) ECULIZUMAB (3,550) CERTOLIZUMAB PEGOL (2,256) ABOBOTULINUMTOXINA (2,170) LEVETIRACETAM (2,161) APREMILAST (1,995) PROPRANOLOL (1,576) CETIRIZINE (1,416) HUMAN IMMUNOGLOBULIN G (1,129) THALIDOMIDE (1,033)

Related Pages

ERENUMAB-AOOE Full Profile All Off label use Drugs ERENUMAB-AOOE Demographics ERENUMAB-AOOE Timeline